Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | RXRA | P19793 | 2/20 | 0.49 |
| ▸ | RXRB | P28702 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.47 |
| ▸ | PTPN5 | P54829 | 4/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23106342 | 0.84 | RXRA (0.42) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL779683 | 0.82 | KIF11 (0.70) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL3681495 | 0.82 | KIF11 (0.53) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL23026518 | 0.81 | ESR1 (0.44) | KIF11CYP3A4ALDH1A1MAPK1 | |
| SCHEMBL25693197 | 0.80 | KIF11 (0.68) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL28423705 | 0.80 | CNR1 (0.53) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL548430 | 0.78 | RXRA (0.53) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL28297682 | 0.78 | PTPN1 (0.58) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL6248959 | 0.78 | KIF11 (0.50) | KIF11RXRARXRBPTPN1PTPN5 | |
| SCHEMBL6982792 | 0.78 | RXRA (0.53) | KIF11RXRARXRBPTPN1PTPN5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230287024-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2023-09-14 | — | — | US | disclosed |
| US-11731995-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20220213132-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2022-07-07 | — | — | US | disclosed |
| US-11352384-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-06-07 | — | — | US | disclosed |
| US-20190211042-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190211042-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | LEF1, ORC3, CRY1 | KIF11 2567/4885RXRA 2844/4885RXRB 3082/4885 |
| US-20220213132-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | LEF1, ORC3, CRY1 | KIF11 2567/4885RXRA 2844/4885RXRB 3082/4885 |
| US-11731995-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same | LEF1, ORC3, CRY1 | KIF11 2567/4885RXRA 2844/4885RXRB 3082/4885 |
| US-11352384-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the same | LEF1, ORC3, CRY1 | KIF11 2567/4885RXRA 2844/4885RXRB 3082/4885 |
| US-20230287024-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE SAME | LEF1, ORC3, CRY1 | KIF11 2567/4885RXRA 2844/4885RXRB 3082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.